Jiang, X-E <br/><br/>
Effects of mesalazine combined with bifid triple viable on intestinal flora, immunoglobulin and levels of cal, MMP-9, and MPO in feces of patients with ulcerative colitis.  [electronic resource] 

 -  European review for medical and pharmacological sciences  01 2020 
 - 935-942 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2284-0729 
<br/><br/><label>Standard No.: </label>10.26355/eurrev_202001_20079  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Inflammatory Agents, Non-Steroidal--administration & dosage<br/>Colitis, Ulcerative--metabolism<br/>Combined Modality Therapy--methods<br/>Feces--microbiology<br/>Female<br/>Gastrointestinal Microbiome--drug effects<br/>Humans<br/>Immunity, Cellular--drug effects<br/>Immunoglobulins--metabolism<br/>Intestinal Mucosa--drug effects<br/>Leukocyte L1 Antigen Complex--metabolism<br/>Male<br/>Matrix Metalloproteinase 9--metabolism<br/>Mesalamine--administration & dosage<br/>Middle Aged<br/>Peroxidase--metabolism<br/>Probiotics--administration & dosage<br/>Treatment Outcome